Antibiotics Market 2025-2029
The antibiotics market is forecasted to grow by USD 18.22 billion during 2024-2029, accelerating at a CAGR of 5.9% during the forecast period. The report on the antibiotics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of infectious diseases, government investment regarding antibiotics, and growing awareness of various diseases and their treatment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's antibiotics market is segmented as below:
By Product
- Broad-spectrum antibiotics
- Narrow-spectrum antibiotics
By Route Of Administration
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
This study identifies the strategic alliances and mergers and acquisitions as one of the prime reasons driving the antibiotics market growth during the next few years. Also, presence of patient assistance programs (PAPs) and growing interest in bacteriophage therapy will lead to sizable demand in the market.
The report on the antibiotics market covers the following areas:
- Antibiotics Market sizing
- Antibiotics Market forecast
- Antibiotics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibiotics market vendors that include Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd., Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline PLC, Incepta Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the antibiotics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.